Table 4.
Average surgical success rates by intralesional injection agent.
| Intralesional Injection Agent | Procedure 1 | Procedure 2 | Procedure 3 |
|---|---|---|---|
| Triamcinolone | |||
| Eltahawy [2] | 19/24 | Not Reported | Not Reported |
| Zhang [14] | * 26/28 | Not Reported | Not Reported |
| Mann [1] | 21/30 | 25/30 | Not Reported |
| Totals (%) | 66/82 (80.5) | 25/30 (83.3) | --- |
| Mitomycin C | |||
| Vanni [7] | 13/18 | 16/18 | Not Reported |
| Redshaw [6] | 32/55 | 41/55 | Not Reported |
| Farrell [5] | 28/37 | Not Reported | Not Reported |
| Nagpal [12] | 30/40 | 35/40 | Not Reported |
| Sourial [13] | 23/29 | 25/29 | Not Reported |
| Rozanski [8] | 56/86 | 71/86 | 77/86 |
| Selvaraj [15] | 8/10 | Not Reported | Not Reported |
| Hacker [4] | ε 23/51 | 35/51 | 40/51 |
| Totals (%) | 213/326 (65.3) | 223/279 (80.0) | 117/137 (85.4) |
| Current Series | 101/123 | 116/123 | Not reported |
| Totals (%) | 101/123 (82.1) | 116/123 (94.3) | --- |
Values are reported as number of patients per total number. * Study protocol of scheduled repeat cystoscopies and injection of triamcinolone at regular intervals. ε Procedure 4 results not included—only study to include data from 4 separate procedures.